ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,039Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 1206

$575K Total Retail Price of All Prescriptions

Rank: 104 out of 1206

529 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 529 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 529 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,748 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 550 467 1 1
OMEPRAZOLE 476 474 2 3
LISINOPRIL 474 418 3 4
FUROSEMIDE 463 433 4 5
LEVOTHYROXINE SODIUM 365 346 5 2
METOPROLOL TARTRATE 307 255 6 9
HYDROCODONE-ACETAMINOPHEN 291 253 S3 7 7
METOPROLOL SUCCINATE 289 271 8 15
PRAVASTATIN SODIUM 241 214 9 21
AMLODIPINE BESYLATE 218 207 10 6
ATORVASTATIN CALCIUM 215 185 11 13
CITALOPRAM HBR 204 183 12 16
HYDROCHLOROTHIAZIDE 201 189 13 11
ALLOPURINOL 197 186 14 24
WARFARIN SODIUM 189 172 15 8
METFORMIN HCL 172 146 16 10
TRAMADOL HCL 161 125 17 17
GABAPENTIN 159 146 18 18
POTASSIUM CHLORIDE 148 125 19 12
TAMSULOSIN HCL 144 133 20 26
ALENDRONATE SODIUM 131 131 21 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 107 22 27
MELOXICAM 102 102 23 35
NAMENDA 100 88 24 36
ATENOLOL 94 79 25 14
ZOLPIDEM TARTRATE 88 87 26 25
DIOVAN 87 87 27 57
NABUMETONE 85 85 28 91
PANTOPRAZOLE SODIUM 84 81 29 54
KLOR-CON 10 83 83 30 93
DONEPEZIL HCL 79 67 31 29
CRESTOR 78 74 32 30
CELEBREX 77 53 33 84
VENLAFAXINE HCL ER 77 37 33 89
FENOFIBRATE 76 70 35 56
DIOVAN HCT 74 74 36 112
DILTIAZEM 24HR CD 73 60 37 67
FLUOXETINE HCL 70 61 38 52
ACTOS 69 61 39 98
BENAZEPRIL HCL 69 69 39 39
LOSARTAN-HYDROCHLOROTHIAZIDE 69 57 39 60
PAROXETINE HCL 65 56 42 53
SPIRONOLACTONE 63 55 43 41
LOSARTAN POTASSIUM 63 44 43 20
RANITIDINE HCL 63 43 43 23
PREDNISONE 61 58 46 28
METFORMIN HCL ER 58 48 47 58
LANTUS SOLOSTAR 56 49 48 85
TRAZODONE HCL 55 48 49 37
NEXIUM 55 47 49 47
LANTUS 55 37 49 38
ADVAIR DISKUS 54 49 52 55
PLAVIX 54 54 52 72
PROAIR HFA 52 36 54 49
AMITRIPTYLINE HCL 52 52 R 54 59
DICLOFENAC SODIUM 51 51 56 104
CLOPIDOGREL 50 50 57 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 22, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.